Literature DB >> 25482293

Inactivation of viruses using novel protein A wash buffers.

Glen R Bolton1, Keith R Selvitelli, Ionela Iliescu, Douglas J Cecchini.   

Abstract

Low pH viral inactivation is typically performed in the eluate pool following the protein A capture step during the manufacturing of monoclonal antibodies and Fc-fusion proteins. However, exposure to low pH has the potential to alter protein quality. To avoid these difficulties, novel wash buffers capable of inactivating viruses while antibodies or Fc-fusion proteins were bound to protein A or mixed mode resins were developed. By equilibrating the column in high salt buffer (2 M ammonium sulfate or 3 M sodium chloride) after loading, the hydrophobic interactions between antibodies and protein A ligands were increased enough to prevent elution at pH 3. The ammonium sulfate was also found to cause binding of an antibody to a mixed mode cation exchange and a mixed mode anion exchange resin at pH values that caused elution in conventional cation and anion exchange resins (pH 3.5 for Capto Adhere and pH 8.0 for Capto MMC), indicating that retention was due to enhanced hydrophobic interactions. The potential of the 2 M ammonium sulfate pH 3 buffer, a 1 M arginine buffer, and a buffer containing the detergent LDAO to inactivate XMuLV virus when used as protein A wash buffers with a 1 hour contact time were studied. The high salt and detergent containing wash buffers provided about five logs of removal, determined using PCR, and complete combined removal and inactivation (> 6 logs), determined by measuring infectivity. The novel protein A washes could provide more rapid, automated viral inactivation steps with lower pool conductivities.
© 2014 American Institute of Chemical Engineers.

Entities:  

Keywords:  Fc-fusion; mixed mode; monoclonal antibody; protein A; purification; viral clearance; viral inactivation

Mesh:

Substances:

Year:  2014        PMID: 25482293     DOI: 10.1002/btpr.2024

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  5 in total

1.  Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.

Authors:  Chen Chen; Tetsuya Wakabayashi; Masaru Muraoka; Feng Shu; Chia Wei Shan; Chong Chor Kun; Ching Tim Jang; Ishin Soehano; Yuichiro Shimizu; Tomoyuki Igawa; Jun-Ichi Nezu
Journal:  MAbs       Date:  2019-03-21       Impact factor: 5.857

2.  Engineering a human IgG2 antibody stable at low pH.

Authors:  Seiji Saito; Hiroshi Namisaki; Keiko Hiraishi; Nobuaki Takahashi; Shigeru Iida
Journal:  Protein Sci       Date:  2020-03-18       Impact factor: 6.725

3.  Discovering Novel Small Molecule Compound for Prevention of Monoclonal Antibody Self-Association.

Authors:  Lok Hin Lui; Christopher F van der Walle; Steve Brocchini; Ajoy Velayudhan
Journal:  Antibodies (Basel)       Date:  2022-06-08

4.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

5.  Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies.

Authors:  Serene W Chen; Darryl Tan; Yuan Sheng Yang; Wei Zhang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.